REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K900. A total of 2 filers reported holding REGULUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $171,000 | +434.4% | 577,300 | +473.3% | 0.00% | – |
| Q4 2021 | $32,000 | -72.9% | 100,700 | -40.9% | 0.00% | – |
| Q3 2021 | $118,000 | +110.7% | 170,300 | +147.5% | 0.00% | – |
| Q2 2021 | $56,000 | -75.7% | 68,800 | -53.3% | 0.00% | – |
| Q1 2021 | $230,000 | +11400.0% | 147,400 | +8088.9% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 1,800 | -64.0% | 0.00% | – |
| Q4 2018 | $5,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,000 | $5,000 | 0.00% |